216 related articles for article (PubMed ID: 33872131)
1. Effect of silver nanoparticles on vancomycin resistant Staphylococcus aureus infection in critically ill patients.
Elsawy S; Elsherif WM; Hamed R
Pathog Glob Health; 2021 Jul; 115(5):315-324. PubMed ID: 33872131
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of the Vancomycin Resistance in
Salah NM; Saafan AE; Salem EH; El Rabey HA; Alsieni MA; Alatawi FA; Alalawy AI; Abeer Mohammed AB
Biomed Res Int; 2022; 2022():7380147. PubMed ID: 35535039
[No Abstract] [Full Text] [Related]
3. Pharmacodynamic activity of ceftobiprole compared with vancomycin versus methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-intermediate Staphylococcus aureus (VISA) and vancomycin-resistant Staphylococcus aureus (VRSA) using an in vitro model.
Zhanel GG; Voth D; Nichol K; Karlowsky JA; Noreddin AM; Hoban DJ
J Antimicrob Chemother; 2009 Aug; 64(2):364-9. PubMed ID: 19454524
[TBL] [Abstract][Full Text] [Related]
4. Emergence of vancomycin-intermediate and -resistant Staphylococcus aureus among methicillin-resistant S. aureus isolated from clinical specimens in the northwest of Iran.
Ghahremani M; Jazani NH; Sharifi Y
J Glob Antimicrob Resist; 2018 Sep; 14():4-9. PubMed ID: 29454049
[TBL] [Abstract][Full Text] [Related]
5. Genotyping of enterotoxigenic methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Staphylococcus aureus (VRSA) among commensal rodents in North Sinai, Egypt.
Eidaroos NH; Youssef AI; El-Sebae A; Enany ME; Farid DS
J Appl Microbiol; 2022 Mar; 132(3):2331-2341. PubMed ID: 34297868
[TBL] [Abstract][Full Text] [Related]
6. First Report on Vancomycin-Resistant Staphylococcus aureus in Bovine and Caprine Milk.
Bhattacharyya D; Banerjee J; Bandyopadhyay S; Mondal B; Nanda PK; Samanta I; Mahanti A; Das AK; Das G; Dandapat P; Bandyopadhyay S
Microb Drug Resist; 2016 Dec; 22(8):675-681. PubMed ID: 26990514
[TBL] [Abstract][Full Text] [Related]
7. Molecular Characterization of Methicillin and Vancomycin Resistant
Jahanshahi A; Zeighami H; Haghi F
Microb Drug Resist; 2018 Dec; 24(10):1529-1536. PubMed ID: 29883257
[No Abstract] [Full Text] [Related]
8. Emergence of vancomycin resistant Staphylococcus aureus (VRSA) from a tertiary care hospital from northern part of India.
Tiwari HK; Sen MR
BMC Infect Dis; 2006 Oct; 6():156. PubMed ID: 17067393
[TBL] [Abstract][Full Text] [Related]
9. Growing Resistance to Vancomycin among Methicillin Resistant Staphylococcus Aureus Isolates from Different Clinical Samples.
Pahadi PC; Shrestha UT; Adhikari N; Shah PK; Amatya R
JNMA J Nepal Med Assoc; 2014; 52(196):977-81. PubMed ID: 26982895
[TBL] [Abstract][Full Text] [Related]
10. In vitro activity of oritavancin against community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA), vancomycin-intermediate S. aureus (VISA), vancomycin-resistant S. aureus (VRSA) and daptomycin-non-susceptible S. aureus (DNSSA).
Saravolatz LD; Pawlak J; Johnson LB
Int J Antimicrob Agents; 2010 Jul; 36(1):69-72. PubMed ID: 20413274
[TBL] [Abstract][Full Text] [Related]
11. Multidrug and vancomycin resistance among clinical isolates of
Olufunmiso O; Tolulope I; Roger C
Afr Health Sci; 2017 Sep; 17(3):797-807. PubMed ID: 29085408
[TBL] [Abstract][Full Text] [Related]
12. Effect of ZnO nanoparticles on methicillin, vancomycin, linezolid resistance and biofilm formation in Staphylococcus aureus isolates.
Abdelraheem WM; Khairy RMM; Zaki AI; Zaki SH
Ann Clin Microbiol Antimicrob; 2021 Aug; 20(1):54. PubMed ID: 34419054
[TBL] [Abstract][Full Text] [Related]
13. Phylogeny of hospital acquired MRSA, and its comparative phenotypic clinico-epidemiology with vancomycin resistant S. aureus (VRSA).
Rehman TU; Aslam R; Aqib AI; Mohsin M; Manzoor A; Shoaib M; Naseer MA; Hasan A; Sattar H; Fakhar-E-Alam Kulyar M; Muzammil I; Yao W
Microb Pathog; 2020 Dec; 149():104537. PubMed ID: 32980474
[TBL] [Abstract][Full Text] [Related]
14. The emergence of vancomycin-resistant Staphylococcus aureus in an intensive care unit in Kerman, Iran.
Fasihi Y; Saffari F; Mansouri S; Kalantar-Neyestanaki D
Wien Med Wochenschr; 2018 Mar; 168(3-4):85-88. PubMed ID: 28424995
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of vancomycin-intermediate Staphylococcus aureus (VISA) and heterogeneous VISA among methicillin-resistant S. aureus with high vancomycin minimal inhibitory concentrations in Taiwan: A multicenter surveillance study, 2012-2013.
Huang SH; Chen YC; Chuang YC; Chiu SK; Fung CP; Lu PL; Wang LS; Wu TL; Wang JT
J Microbiol Immunol Infect; 2016 Oct; 49(5):701-707. PubMed ID: 26320398
[TBL] [Abstract][Full Text] [Related]
16. Global prevalence and distribution of vancomycin resistant, vancomycin intermediate and heterogeneously vancomycin intermediate Staphylococcus aureus clinical isolates: a systematic review and meta-analysis.
Shariati A; Dadashi M; Moghadam MT; van Belkum A; Yaslianifard S; Darban-Sarokhalil D
Sci Rep; 2020 Jul; 10(1):12689. PubMed ID: 32728110
[TBL] [Abstract][Full Text] [Related]
17. Molecular characterization of vancomycin-resistant Staphylococcus aureus isolated from bovine milk.
Muzammil I; Ijaz M; Saleem MH; Ali MM
Zoonoses Public Health; 2023 Aug; 70(5):420-433. PubMed ID: 37165559
[TBL] [Abstract][Full Text] [Related]
18. High prevalence of MRSA and VRSA among inpatients of Mettu Karl Referral Hospital, Southwest Ethiopia.
Kejela T; Dekosa F
Trop Med Int Health; 2022 Aug; 27(8):735-741. PubMed ID: 35686989
[TBL] [Abstract][Full Text] [Related]
19. [Evaluation of antibiotic susceptibilities and VISA-VRSA rates among MRSA strains isolated from hospitalized patients in intensive care units of hospitals in seven provinces of Turkey].
Cesur S; Irmak H; Simşek H; Cöplü N; Kılıç H; Arslan U; Bayramoğlu G; Baysan BO; Gülay Z; Hoşoğlu S; Berktaş M; Gencer S; Demiröz AP; Esen B; Karabiber N; Aydın F; Yalçın AN
Mikrobiyol Bul; 2012 Jul; 46(3):352-8. PubMed ID: 22951647
[TBL] [Abstract][Full Text] [Related]
20. Delafloxacin activity against Staphylococcus aureus with reduced susceptibility or resistance to methicillin, vancomycin, daptomycin or linezolid.
Saravolatz LD; Pawlak JM; Wegner C
J Antimicrob Chemother; 2020 Sep; 75(9):2605-2608. PubMed ID: 32542310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
